Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.

BACKGROUND:According to studies by the National Kidney Foundation and Food and Drug Administration, 30% and 40% declines in estimated glomerular filtration rate (eGFR) could be used as surrogate endpoints of end-stage renal disease (ESRD). However, the benefits of using these endpoints in diabetic p...

Full description

Bibliographic Details
Main Authors: Megumi Oshima, Tadashi Toyama, Masakazu Haneda, Kengo Furuichi, Tetsuya Babazono, Hiroki Yokoyama, Kunitoshi Iseki, Shinichi Araki, Toshiharu Ninomiya, Shigeko Hara, Yoshiki Suzuki, Masayuki Iwano, Eiji Kusano, Tatsumi Moriya, Hiroaki Satoh, Hiroyuki Nakamura, Miho Shimizu, Akinori Hara, Hirofumi Makino, Takashi Wada, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6072050?pdf=render